Drug utilization study for Elvanse® / Tyvense® / Elvanse® Adult in Europe

26/09/2016
23/04/2024
EU PAS number:
EUPAS15507
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

SHP489-813 Elvanse DUS Protocol Version 3.0_26Feb2018 _clean_Redacted

English (3.87 MB - PDF) View document
Study results
Study results

SHP489-813 Elvanse DUS Fifth R_FINAL_Watermarked

English (1.27 MB - PDF) View document
Study report
Other information
Publications
Study publications
Siffel C, Page M, Maxwell T, Thun B, Kolb N, Rosenlund M, von Bredow D, Keja J…